DPI Cap . Salflu 50 mcg+250 mcg ( 50 Pcs )

Salflu is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:

• Patients not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short acting β2-agonist or
• Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.